|
|
On-Demand Webinar: Current Strategies for Leveraging Preclinical Capabilities in China
Cambridge Healthtech Associates' complimentary web conference entitled Current Strategies for Leveraging Preclinical Capabilities in China, was originally held on Thursday, June 12, 2008 at 2:00 PM EDT (8:00 PM CEST).
Register for the On-Demand Recording using the form below.
This complimentary, online session focused on the variety of ways small and mid-size pharmas are increasingly leveraging China to lower the cost and duration of their preclinical development programs. Based on our experience rigorously evaluating preclinical CROs in China, we have made the following observations:
- Preclinical capabilities in China can now be leveraged by small and mid-size biopharmas for substantial benefit – including cost, speed and access to the Chinese market.
- China’s CRO sector has greatly matured, and now many CROs offer robust global standard preclinical capabilities
- The challenge for small and mid-size biopharmas is to determine which partners to work with in China and for which studies.
|